Govt Job for M.Pharm, M.Sc as Junior Research Fellow at NIAB

NIAB is an autonomous and premier institute of the Department of Biotechnology (DBT), Government of India.

The Institute aims to develop and harness novel and emerging biotechnological tools and applications, and take up research in cutting-edge areas for improving animal health and productivity as well as contribute to human health and welfare.

Walk-in interview for One position of JRF under DBT funded project entitled “Molecular platform for epidemiology, disease mapping and development of diagnostics for economically important diseases of ducks” of Dr. Madhuri Subbiah (non-NER PI) initially for a period of less than three months.

Post : Junior Research Fellow

Fellowship amount : Rs. 31,000 +24% HRA.

Eligibility : Post Graduate degree in professional courses (M.Pharm / M. Tech in Life Sciences / M. V. Sc. etc.) or Post Graduate Degree in Life Sciences (Biotechnology/Biochemistry/Microbiology) with NET qualification.

Desired Experience : Molecular Biology techniques. Candidates having prior experience in molecular techniques involving nucleic acid isolation, quantification, amplification and with cell culture experiences will be preferred

Upper Age limit : 30 years

Interested eligible candidates are advised to attend the online walk-in interview on 23-07-2021 from 02:00 pm to 05:00 pm.

Those interested are requested to kindly email a photograph and copies of documents in support of date of birth, educational qualifications, experience certificates etc. to madhuri@niab.org.in at least two days in advance of the above interview date. Online Interview Link will be sent to the candidates.

Related Posts

  • Pharma
  • July 22, 2025
  • 134 views
DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

The Directorate General of Foreign Trade ( DGFT ) has notified an extension in the deadline for submitting applications for the export of Pharma Grade Sugar. This was communicated through Trade Notice…

  • Pharma
  • July 16, 2025
  • 562 views
Aurobindo, Cipla, Viatris to make, market long-acting injectable HIV drug

Generic drugmakers Aurobindo Pharma, Cipla and Viatris will develop, manufacture and supply long-acting injectable cabotegravir (CAB LA) for HIV treatment in 133 countries. This follows ViiV Healthcare, a company focused…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

10, 000 Km is just a Number for Intercontinental Tele Surgery by SSIMantra

10, 000 Km is just a Number for Intercontinental Tele Surgery by SSIMantra

DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

Bihar Healthcare is poised to be embraced by Robotic Surgery Mantra

Bihar Healthcare is poised to be embraced by Robotic Surgery Mantra

Aurobindo, Cipla, Viatris to make, market long-acting injectable HIV drug

Aurobindo, Cipla, Viatris to make, market long-acting injectable HIV drug